In Vitro Drug Release Testing and In Vivo/In Vitro Correlation for Long Acting Implants and Injections
- Michail Kastellorizios,
- Diane J. Burgess
- … show all 2 hide
Purchase on Springer.com
$29.95 / €24.95 / £19.95 *
* Final gross prices may vary according to local VAT.
Abstract
An advantage of long acting implants and injections is their ability to maintain a relatively constant drug concentration at the site of interest. In vitro drug release testing, particularly where an in vivo/in vitro relationship has been established, can help in ensuring in vivo performance. There are various in vitro release testing methods, which are chosen, based on availability, dosage form specifications and drug properties. These are categorized into three groups: sample and separate, flow-through and dialysis. Although there are currently no standard methods for in vitro release testing of controlled release parenterals, standard dissolution apparatus specified by the United States Pharmacopeia have been adapted in some cases and the development of compendial monographs is anticipated. An in vivo/in vitro correlation can predict the bioavailability characteristics of a product based on release in vitro.
Look
Inside
Within this Chapter
- Introduction
- Parameters to Consider When Developing In Vitro Release Tests
- Methodology
- Special Case: In Vitro Release from Lipophilic Solutions
- Comparison of In Vitro Release Profiles
- In Vivo/In Vitro Correlations
- Conclusions
- References
- References
Other actions
Related Content
Supplementary Material (0)
References (123)
- Adeyeye CM, Price JC (1994) Development and evaluation of sustained-release ibuprofen-wax microspheres. II. In vitro dissolution studies. Pharm Res 11(4):575–579
- D’Souza SS, DeLuca PP (2005) Development of a dialysis in vitro release method for biodegradable microspheres. AAPS PharmSciTech 6(2):E323–E328
- Ghaly ES, Sepulveda S (1996) In-vitro evaluation of sustained release ibuprofen microspheres. P R Health Sci J 15(2):97–100
- Hickey T, Kreutzer D, Burgess DJ, Moussy F (2002) Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices. Biomaterials 23(7):1649–1656
- Lindberg NO, Persson CG (1972) In vitro and in vivo evaluation of sustained release tablets containing norephedrine chloride. Acta Pharm Suec 9(3):237–248
- Nakajima T, Takashima Y, Iida K, Mitsuta H, Koishi M (1987) Preparation and in vitro evaluation of sustained-release suppositories containing microencapsulated indomethacin. Chem Pharm Bull (Tokyo) 35(3):1201–1206
- Schneid TR (1992) An in vitro analysis of a sustained release system for the treatment of denture stomatitis. Spec Care Dentist 12(6):245–250
- Wada R, Hyon SH, Nakamura T, Ikada Y (1991) In vitro evaluation of sustained drug release from biodegradable elastomer. Pharm Res 8(10):1292–1296
- Waters LJ, Pavlakis E (2007) In vitro controlled drug release from loaded microspheres–dose regulation through formulation. J Pharm Pharm Sci 10(4):464–472
- Yang TT, Swarbrick J (1986) Sustained-release delivery systems, II: in vitro dissolution of 4,4′-sulfonylbisbenzamine (dapsone)–N-dodecanoyl-4,4′-sulfonylbisbenzamine comelts. J Pharm Sci 75(3):264–270
- De Souza EB, Zaczek R, Culp S, Appel NM, Contrera JF (1991) Comparison of the effects of repeated oral versus subcutaneous fenfluramine administration on rat brain monoamine neurons: pharmacokinetic and dose-response data. Pharmacol Biochem Behav 39(4):963–969
- Konsue N, Kirkpatrick J, Kuhnert N, King LJ, Ioannides C (2010) Repeated oral administration modulates the pharmacokinetic behavior of the chemopreventive agent phenethyl isothiocyanate in rats. Mol Nutr Food Res 54(3):426–432
- Rainsford KD, Stetsko PI, Sirko SP, Debski S (2003) Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease. J Pharm Pharmacol 55(5):661–668
- Thoren MC, Wivall-Helleryd IL, Blum WF, Hall KE (1994) Effects of repeated subcutaneous administration of recombinant human insulin-like growth factor I in adults with growth hormone deficiency. Eur J Endocrinol 131(1):33–40
- Patil SD, Papadimitrakopoulos F, Burgess DJ (2004) Dexamethasone-loaded poly(lactic-co-glycolic) acid microspheres/poly(vinyl alcohol) hydrogel composite coatings for inflammation control. Diabetes Technol Ther 6(6):887–897
- Abrahamsson B, Alpsten M, Bake B, Jonsson UE, Eriksson-Lepkowska M, Larsson A (1998) Drug absorption from nifedipine hydrophilic matrix extended-release (ER) tablet-comparison with an osmotic pump tablet and effect of food. J Control Release 52(3):301–310
- Okimoto K, Miyake M, Ohnishi N, Rajewski RA, Stella VJ, Irie T, Uekama K (1998) Design and evaluation of an osmotic pump tablet (OPT) for prednisolone, a poorly water soluble drug, using (SBE)7m-beta-CD. Pharm Res 15(10):1562–1568
- Okimoto K, Rajewski RA, Stella VJ (1999) Release of testosterone from an osmotic pump tablet utilizing (SBE)7m-beta-cyclodextrin as both a solubilizing and an osmotic pump agent. J Control Release 58(1):29–38
- Pope DG, Wilkinson PK, Egerton JR, Conroy J (1985) Oral controlled-release delivery of ivermectin in cattle via an osmotic pump. J Pharm Sci 74(10):1108–1110
- Rani M, Surana R, Sankar C, Mishra B (2003) Development and biopharmaceutical evaluation of osmotic pump tablets for controlled delivery of diclofenac sodium. Acta Pharm 53(4):263–273
- Theeuwes F, Swanson D, Wong P, Bonsen P, Place V, Heimlich K, Kwan KC (1983) Elementary osmotic pump for indomethacin. J Pharm Sci 72(3):253–258
- Gao P, Xu H, Ding P, Gao Q, Sun J, Chen D (2007) Controlled release of huperzine A from biodegradable microspheres: in vitro and in vivo studies. Int J Pharm 330(1–2):1–5
- Bhardwaj U, Sura R, Papadimitrakopoulos F, Burgess DJ (2007) Controlling acute inflammation with fast releasing dexamethasone-PLGA microsphere/pva hydrogel composites for implantable devices. J Diabetes Sci Technol 1(1):8–17
- Bonny JD, Kyowa M (1995) Use of in vitro release tests for the prediction of the in vivo behavior and the development of flucytosine controlled-release capsules. J Pharm Sci 84(5):619–623
- Brock MH, Dansereau RJ, Patel VS (1994) Use of in vitro and in vivo data in the design, development, and quality control of sustained-release decongestant dosage forms. Pharmacotherapy 14(4):430–437
- Khidr SH, Niazy EM, el-Sayed YM (1998) Development and in-vitro evaluation of sustained-release meclofenamic acid microspheres. J Microencapsul 15(2):153–162
- Wu LS, McCormick TJ, Chang RK, Pang J, McCummings T, Ramos M, Hussain MA (1999) Development of an unconventional in vitro drug release test method for a bile acid sequestrant, DMP 504, tablet. Pharm Res 16(7):1136–1139
- Zhang L, Parsons DL, Navarre C, Kompella UB (2002) Development and in-vitro evaluation of sustained release poloxamer 407 (P407) gel formulations of ceftiofur. J Control Release 85(1–3):73–81
- Malinowski HJ (1997) The role of in vitro-in vivo correlations (IVIVC) to regulatory agencies. Adv Exp Med Biol 423:261–268
- FDA (1997) Bioavailability and bioequivalence studies for orally administered drug products – general considerations. Food and Drug Administration Center for Drug Evaluation and Research Guidance for Industry
- FDA (1997c) Extended release oral dosage forms: development, evaluation and application of in vitro/in vivo correlations
- Brown CK, Chokshi HP, Nickerson B, Reed RA, Rohrs BR, Shah PA (2004) Acceptable analytical practices for dissolution testing of poorly soluble compounds. Pharmaceut Tech 28(12):56–65
- Klose D, Delplace C, Siepmann J (2011) Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles. Int J Pharm 404(1–2):75–82
- Guy RH, Hadgraft J (1981) Theoretical comparison of release rates of drugs into sink and nonsink conditions. J Pharm Sci 70(11):1243–1245
- Gupta KC, Ravi Kumar MN (2001) pH dependent hydrolysis and drug release behavior of chitosan/poly(ethylene glycol) polymer network microspheres. J Mater Sci Mater Med 12(9):753–759
- Kim H, Burgess DJ (2002) Effect of drug stability on the analysis of release data from controlled release microspheres. J Microencapsul 19(5):631–640
- Voisine JM, Zolnik BS, Burgess DJ (2008) In situ fiber optic method for long-term in vitro release testing of microspheres. Int J Pharm 356(1–2):206–211
- Burgess DJ, Crommelin DJ, Hussain AS, Chen ML (2004) Assuring quality and performance of sustained and controlled release parenterals: EUFEPS workshop report. AAPS J 6(1):100–111
- Burgess DJ, Hussain AS, Ingallinera TS, Chen ML (2002) Assuring quality and performance of sustained and controlled release parenterals: AAPS workshop report, co-sponsored by FDA and USP. Pharm Res 19(11):1761–1768
- Martinez MN, Rathbone MJ, Burgess D, Huynh M (2010) Breakout session summary from AAPS/CRS joint workshop on critical variables in the in vitro and in vivo performance of parenteral sustained release products. J Control Release 142(1):2–7
- Collier JW, Thakare M, Garner ST, Israel B, Ahmed H, Granade S, Strong DL, Price JC, Capomacchia AC (2009) Accelerated dissolution testing for controlled release microspheres using the flow-through dissolution apparatus. Pharm Dev Technol 14(1):9–17
- D’Souza SS, Faraj JA, DeLuca PP (2005) A model-dependent approach to correlate accelerated with real-time release from biodegradable microspheres. AAPS PharmSciTech 6(4):E553–E564
- Shameem M, Lee H, DeLuca PP (1999) A short term (accelerated release) approach to evaluate peptide release from PLGA depot-formulations. AAPS PharmSci 1(3):E7
- Wang Y, Lapitsky Y, Kang CE, Shoichet MS (2009) Accelerated release of a sparingly soluble drug from an injectable hyaluronan-methylcellulose hydrogel. J Control Release 140(3):218–223
- Crail DJ, Tunis A, Dansereau R (2004) Is the use of a 200 ml vessel suitable for dissolution of low dose drug products? Int J Pharm 269(1):203–209
- Cupera J, Lansky P (2010) Random effects in drug dissolution. Eur J Pharm Sci 41(3–4):430–439
- Gao Z, Ahadi S, Moore TW, Doub WH, Westenberger BJ, Buhse LF (2010) Effects of vessel geometric irregularity on dissolution test results. J Pharm Sci 100(3):1093–1101
- Bhardwaj U, Burgess DJ (2010) A novel USP apparatus 4 based release testing method for dispersed systems. Int J Pharm 388(1–2):287–294
- Iyer SS, Barr WH, Karnes HT (2007) A ‘biorelevant’ approach to accelerated in vitro drug release testing of a biodegradable, naltrexone implant. Int J Pharm 340(1–2):119–125
- Rawat A, Burgess DJ (2011) USP apparatus 4 method for in vitro release testing of protein loaded microspheres. Int J Pharm 409(1–2):178–184
- Bain DF, Munday DL, Smith A (1999) Modulation of rifampicin release from spray-dried microspheres using combinations of poly-(dl-lactide). J Microencapsul 16(3):369–385
- Deng X, Zhou S, Li X, Zhao J, Yuan M (2001) In vitro degradation and release profiles for poly-dl-lactide-poly(ethylene glycol) microspheres containing human serum albumin. J Control Release 71(2):165–173
- Diaz RV, Llabres M, Evora C (1999) One-month sustained release microspheres of 125I-bovine calcitonin. In vitro-in vivo studies. J Control Release 59(1):55–62
- Dong CM, Guo YZ, Qiu KY, Gu ZW, Feng XD (2005) In vitro degradation and controlled release behavior of D, L-PLGA50 and PCL-b-D, L-PLGA50 copolymer microspheres. J Control Release 107(1):53–64
- Giammona G, Pitarresi G, Tomarchio V, De Guidi G, Giuffrida S (1998) Swellable microparticles containing Suprofen: evaluation of in vitro release and photochemical behaviour. J Control Release 51(2–3):249–257
- Jackson JK, Hung T, Letchford K, Burt HM (2007) The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers. Int J Pharm 342(1–2):6–17
- Liu FI, Kuo JH, Sung KC, Hu OY (2003) Biodegradable polymeric microspheres for nalbuphine prodrug controlled delivery: in vitro characterization and in vivo pharmacokinetic studies. Int J Pharm 257(1–2):23–31
- Liu WH, Song JL, Liu K, Chu DF, Li YX (2005) Preparation and in vitro and in vivo release studies of Huperzine A loaded microspheres for the treatment of Alzheimer’s disease. J Control Release 107(3):417–427
- Lu J, Jackson JK, Gleave ME, Burt HM (2008) The preparation and characterization of anti-VEGFR2 conjugated, paclitaxel-loaded PLLA or PLGA microspheres for the systemic targeting of human prostate tumors. Cancer Chemother Pharmacol 61(6):997–1005
- Murty SB, Goodman J, Thanoo BC, DeLuca PP (2003) Identification of chemically modified peptide from poly(d,l-lactide-co-glycolide) microspheres under in vitro release conditions. AAPS PharmSciTech 4(4):E50
- Schaefer MJ, Singh J (2002) Effect of tricaprin on the physical characteristics and in vitro release of etoposide from PLGA microspheres. Biomaterials 23(16):3465–3471
- Yen SY, Sung KC, Wang JJ, Yoa-Pu Hu O (2001) Controlled release of nalbuphine propionate from biodegradable microspheres: in vitro and in vivo studies. Int J Pharm 220(1–2):91–99
- Latha MS, Lal AV, Kumary TV, Sreekumar R, Jayakrishnan A (2000) Progesterone release from glutaraldehyde cross-linked casein microspheres: in vitro studies and in vivo response in rabbits. Contraception 61(5):329–334
- Negrin CM, Delgado A, Llabres M, Evora C (2001) In vivo-in vitro study of biodegradable methadone delivery systems. Biomaterials 22(6):563–570
- Park TG, Yong Lee H, Sung Nam Y (1998) A new preparation method for protein loaded poly(d,l-lactic-co-glycolic acid) microspheres and protein release mechanism study. J Control Release 55(2–3):181–191
- Bodmeier R, McGinity JW (1987) Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. II. Some process parameters influencing the preparation and properties of microspheres. J Microencapsul 4(4):289–297
- Bodmeier R, McGinity JW (1987) The preparation and evaluation of drug-containing poly(dl-lactide) microspheres formed by the solvent evaporation method. Pharm Res 4(6):465–471
- Hatzi P, Mourtas S, Klepetsanis PG, Antimisiaris SG (2007) Integrity of liposomes in presence of cyclodextrins: effect of liposome type and lipid composition. Int J Pharm 333(1–2):167–176
- Gray V, Kelly G, Xia M, Butler C, Thomas S, Mayock S (2009) The science of USP 1 and 2 dissolution: present challenges and future relevance. Pharm Res 26(6):1289–1302
- Aubert-Pouessel A, Venier-Julienne MC, Clavreul A, Sergent M, Jollivet C, Montero-Menei CN, Garcion E, Bibby DC, Menei P, Benoit JP (2004) In vitro study of GDNF release from biodegradable PLGA microspheres. J Control Release 95(3):463–475
- Balasubramaniam J, Srinatha A, Pandit JK (2008) Studies on indomethacin intraocular implants using different in vitro release methods. Indian J Pharm Sci 70(2):216–221
- Iyer SS, Barr WH, Dance ME, Coleman PR, Karnes HT (2007) A ‘biorelevant’ system to investigate in vitro drug released from a naltrexone implant. Int J Pharm 340(1–2):104–118
- Mallarde D, Boutignon F, Moine F, Barre E, David S, Touchet H, Ferruti P, Deghenghi R (2003) PLGA-PEG microspheres of teverelix: influence of polymer type on microsphere characteristics and on teverelix in vitro release. Int J Pharm 261(1–2):69–80
- Seidlitz A, Nagel S, Semmling B, Grabow N, Martin H, Senz V, Harder C, Sternberg K, Schmitz KP, Kroemer HK, Weitschies W (2010) Examination of drug release and distribution from drug-eluting stents with a vessel-simulating flow-through cell. Eur J Pharm Biopharm 78(1):36–48
- USP (2010a) <711> Dissolution. The United States Pharmacopeia and National Formularity USP 33–NF 28. Rockville, MD
- Zolnik BS, Burgess DJ (2008) Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres. J Control Release 127(2):137–145
- Zolnik BS, Leary PE, Burgess DJ (2006) Elevated temperature accelerated release testing of PLGA microspheres. J Control Release 112(3):293–300
- Zolnik BS, Raton J-L, Burgess DJ (2005) Application of USP Apparatus 4 and in situ fiber optic analysis to microsphere release testing. Dissolut Technol
- Aubert-Pouessel A, Bibby DC, Venier-Julienne MC, Hindre F, Benoit JP (2002) A novel in vitro delivery system for assessing the biological integrity of protein upon release from PLGA microspheres. Pharm Res 19(7):1046–1051
- Longo WE, Goldberg EP (1985) Hydrophilic albumin microspheres. Methods Enzymol 112:18–26
- Martinez M, Rathbone M, Burgess D, Huynh M (2008) In vitro and in vivo considerations associated with parenteral sustained release products: a review based upon information presented and points expressed at the 2007 Controlled Release Society Annual Meeting. J Control Release 129(2):79–87
- Rathbone MJ, Martinez MN, Huynh M, Burgess DJ (2008) CRS/AAPS joint workshop on critical variables in the in vitro and in vivo performance of parenteral sustained-release products. J Control Release 142(1):2–7
- Rawat A, Erika S, Shah VP, Burgess DJ (2011) Validation of USP apparatus 4 method for microsphere in vitro release testing. Int J Pharm 409(1–2):178–184
- Chidambaram N, Burgess DJ (1999) A novel in vitro release method for submicron sized dispersed systems. AAPS PharmSci 1(3):E11
- Forrest ML, Won CY, Malick AW, Kwon GS (2006) In vitro release of the mTOR inhibitor rapamycin from poly(ethylene glycol)-b-poly(epsilon-caprolactone) micelles. J Control Release 110(2):370–377
- Howze JM, Billups NF (1966) Drug release from ointment bases: characteristics, measurement, and evaluation. II. Dialysis cell method. Am J Pharm Sci Support Public Health 138(5):193–203
- Kostanski JW, DeLuca PP (2000) A novel in vitro release technique for peptide containing biodegradable microspheres. AAPS PharmSciTech 1(1):E4
- Lewis KJ, Irwin WJ, Akhtar S (1998) Development of a sustained-release biodegradable polymer delivery system for site-specific delivery of oligonucleotides: characterization of P(LA-GA) copolymer microspheres in vitro. J Drug Target 5(4):291–302
- Ma L, Liu M, Liu H, Chen J, Cui D (2010) In vitro cytotoxicity and drug release properties of pH- and temperature-sensitive core-shell hydrogel microspheres. Int J Pharm 385(1–2):86–91
- Shabbits JA, Chiu GN, Mayer LD (2002) Development of an in vitro drug release assay that accurately predicts in vivo drug retention for liposome-based delivery systems. J Control Release 84(3):161–170
- Zhou YX, Li SL, Fu HL, Cheng SX, Zhang XZ, Zhuo RX (2008) Fabrication and in vitro drug release study of microsphere drug delivery systems based on amphiphilic poly-alpha, beta-[N-(2-hydroxyethyl)-l-aspartamide]-g-poly(l-lactide) graft copolymers. Colloids Surf B Biointerfaces 61(2):164–169
- Zhuo RX, Du B, Lu ZR (1999) In vitro release of 5-fluorouracil with cyclic core dendritic polymer. J Control Release 57(3):249–257
- Schultz K, Mollgaard B, Frokjaer S, Larsen C (1997) Rotating dialysis cell as in vitro release method for oily parenteral depot solutions. Int J Pharm 157(2):163–169
- Yamazaki M, Itoh S, Sasaki N, Tanabe K, Uchiyama M (1993) Modification of the dialysis membrane method for drug release from suppositories. Pharm Res 10(6):927–929
- Burgess DJ, Crommelin DJ, Hussain AS, Chen ML (2004) Assuring quality and performance of sustained and controlled release parenterals: EUFEPS workshop report. AAPS PharmSci 6(1):E11
- Burgess DJ, Hussain AS, Ingallinera TS, Chen ML (2002) Assuring quality and performance of sustained and controlled release parenterals: workshop report. AAPS PharmSci 4(2):E7
- Nastruzzi C, Esposito E, Cortesi R, Gambari R, Menegatti E (1994) Kinetics of bromocriptine release from microspheres: comparative analysis between different in vitro models. J Microencapsul 11(5):565–574
- Abdel-Mottaleb MM, Lamprecht A (2011) Standardized in vitro drug release test for colloidal drug carriers using modified USP dissolution apparatus I. Drug Dev Ind Pharm 37(2):178–184
- Baxter JL, Kukura J, Muzzio FJ (2005) Shear-induced variability in the United States pharmacopeia apparatus 2: modifications to the existing system. AAPS J 7(4):E857–E864
- USP (2010b) <724> Drug release. The United States Pharmacopeia and National Formularity USP 33–NF 28
- Al-Hindawi MK, James KC, Nicholls PJ (1987) Influence of solvent on the availability of testosterone propionate from oily, intramuscular injections in the rat. J Pharm Pharmacol 39(2):90–95
- Dreyfuss J, Ross JJ Jr, Shaw JM, Miller I, Schreiber EC (1976) Release and elimination of 14C-fluphenazine enanthate and decanoate esters administered in sesame oil to dogs. J Pharm Sci 65(4):502–507
- Jann MW, Ereshefsky L, Saklad SR (1985) Clinical pharmacokinetics of the depot antipsychotics. Clin Pharmacokinet 10(4):315–333
- Kakemi K, Sezaki H, Muranishi S, Ogata H, Giga K (1972) Mechanism of intestinal absorption of drugs from oil in water emulsions. II. Absorption from oily solutions. Chem Pharm Bull (Tokyo) 20(4):715–720
- Larsen DB, Parshad H, Fredholt K, Larsen C (2002) Characteristics of drug substances in oily solutions. Drug release rate, partitioning and solubility. Int J Pharm 232(1–2):107–117
- Larsen SW, Frost AB, Ostergaard J, Marcher H, Larsen C (2008) On the mechanism of drug release from oil suspensions in vitro using local anesthetics as model drug compounds. Eur J Pharm Sci 34(1):37–44
- Larsen SW, Ostergaard J, Friberg-Johansen H, Jessen MN, Larsen C (2006) In vitro assessment of drug release rates from oil depot formulations intended for intra-articular administration. Eur J Pharm Sci 29(5):348–354
- Luo JP, Hubbard JW, Midha KK (1998) The roles of depot injection sites and proximal lymph nodes in the presystemic absorption of fluphenazine decanoate and fluphenazine: ex vivo experiments in rats. Pharm Res 15(9):1485–1489
- Minto CF, Howe C, Wishart S, Conway AJ, Handelsman DJ (1997) Pharmacokinetics and pharmacodynamics of nandrolone esters in oil vehicle: effects of ester, injection site and injection volume. J Pharmacol Exp Ther 281(1):93–102
- Radd BL, Newman AC, Fegely BJ, Chrzanowski FA, Lichten JL, Walkling WD (1985) Development of haloperidol in oil injection formulations. J Parenter Sci Technol 39(1):48–51
- Soderberg L, Dyhre H, Roth B, Bjorkman S (2002) In-vitro release of bupivacaine from injectable lipid formulations investigated by a single drop technique–relation to duration of action in-vivo. J Pharm Pharmacol 54(6):747–755
- Soderberg L, Dyhre H, Roth B, Bjorkman S (2006) The “inverted cup” – a novel in vitro release technique for drugs in lipid formulations. J Control Release 113(1):80–88
- Weng Larsen S, Larsen C (2009) Critical factors influencing the in vivo performance of long acting lipophilic solutions–impact on in vitro release method design. AAPS J 11(4):762–770
- FDA (1997) Dissolution testing of immediate release solid oral dosage forms. Food and Drug Administration Center for Drug Evaluation and Research Guidance for Industry
- Moore J, Flanner HH (1996) Mathematical comparison of dissolution profiles. Pharm Tech 20:64–74
- Sathe PM, Tsong Y, Shah VP (1996) In-vitro dissolution profile comparison: statistics and analysis, model dependent approach. Pharm Res 13(12):1799–1803
- EMEA (1999) NfG on quality of modified release products
- Emami J (2006) In vitro–in vivo correlation: from theory to applications. J Pharm Pharm Sci 9(2):169–189
- Schliecker G, Schmidt C, Fuchs S, Ehinger A, Sandow J, Kissel T (2004) In vitro and in vivo correlation of buserelin release from biodegradable implants using statistical moment analysis. J Control Release 94(1):25–37
- Brendel E (2008) BCS-based biowaivers – unresolved issues summary/conclusions of session II. In: EUFEPS network conference 2008 on new regulations in bioequivalence: revised European CHMP note for guidance
- Chu DF, Fu XQ, Liu WH, Liu K, Li YX (2006) Pharmacokinetics and in vitro and in vivo correlation of huperzine A loaded poly(lactic-co-glycolic acid) microspheres in dogs. Int J Pharm 325(1–2):116–123
- Kim TK, Burgess DJ (2002) Pharmacokinetic characterization of 14C-vascular endothelial growth factor controlled release microspheres using a rat model. J Pharm Pharmacol 54(7):897–905
- Sirisuth N, Eddington ND (2002) The influence of first pass metabolism on the development and validation of an IVIVC for metoprolol extended release tablets. Eur J Pharm Biopharm 53(3):301–309
About this Chapter
- Title
- In Vitro Drug Release Testing and In Vivo/In Vitro Correlation for Long Acting Implants and Injections
- Book Title
- Long Acting Injections and Implants
- Pages
- pp 475-503
- Copyright
- 2012
- DOI
- 10.1007/978-1-4614-0554-2_23
- Print ISBN
- 978-1-4614-0553-5
- Online ISBN
- 978-1-4614-0554-2
- Series Title
- Advances in Delivery Science and Technology
- Publisher
- Springer US
- Copyright Holder
- Controlled Release Society
- Additional Links
- Topics
- Industry Sectors
- eBook Packages
- Editors
-
-
Jeremy C. Wright
(ID1)
-
Diane J. Burgess
(ID2)
-
Jeremy C. Wright
- Editor Affiliations
-
- ID1.
- ID2.
- Authors
- Author Affiliations
-
- 1. Department of Pharmaceutical Sciences, School of Pharmacy, University of Connecticut, 69 North Eagleville Road U3092, Storrs, CT, 06269, USA
Continue reading...
To view the rest of this content please follow the download PDF link above.